Views & Analysis Inhalation technology: the future of effective respiratory t... Simon Moore discusses non-clinical development channels: technical strategies, formulations and devices.
News Breathing space for GSK as Mylan's Advair copy rejected Stay of execution for ageing blockbuster
News Propeller Health set for expansion with latest funding round $21.5 million in funding will be used to expand its existing roster of digitally-guided therapy solutions.
News GSK ends decades-long hiatus in oral antibiotics for UTIs The FDA has approved GSK's Blujepa, the first new-mechanism oral antibiotic for uncomplicated UTIs in nearly 30 years, after a priority review.
Sales & Marketing Sponsored Health Trends 2025: Reimagining What's Possible Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm GMT - 4 pm CET, in our webinar sponsored by Syneos Health, entitled ‘Health Trends 2025: Reimagining What's Possibl
